Empowerment is one of the most important things I try to teach people.
In all of my newsletters, I use the knowledge I've gained through my years on Wall Street, as an eye doctor, and beyond to help you live a better life.
Empowerment is one of the most important things I try to teach people.
In all of my newsletters, I use the knowledge I've gained through my years on Wall Street, as an eye doctor, and beyond to help you live a better life.
You're flooding our inbox with questions...
So we'll get straight into the topics that are on your mind.
If you have a question you want answered, send it to us at[email protected].
Q: I already subscribe to the various newsletters and enjoy the read. How do I go about getting a digital copy of the [The Living Cure]? – S.G.
A: In The Living Cure, I talk about the steps you need to take immediately after a cancer diagnosis, 10 questions you must ask your doctor, and a revolutionary new cancer treatment. If you're not a subscriber, you can learn more here.
Current Retirement Millionaire subscribers can read a digital copy of The Living Cure here.
And if you haven't already, don't forget to watch our video on this cutting-edge cancer treatment.
Q: You mention freezing your credit through the three credit reporting agencies. Exactly how does that work? Does that only freeze new credit lines or does that also freeze established credit lines such as a credit card and/or established home equity lines? – W.M.
A: A credit freeze limits third-party access to your credit report. That means that lenders can't see your credit report. This prevents thieves from opening a line of credit or taking out a loan in your name. But it also means you can't do those things. If you're applying for a job or trying to rent a home, remember that employers and landlords can't access your credit report.
A credit freeze doesn't stop activity on lines of credit you already have open. So you can keep using your credit cards as you normally would. But if you're looking for a new place to live, hunting for a new job, or trying to get a loan, you'll need to temporarily lift the freeze.
[optin_form id="73"]
"Are you getting paid indirectly by the drug manufacturers to come out with a video like this?"
This isn't the first time a reader has accused us of siding with Big Pharma, but it shocks us each time. And it makes us wonder if this particular commenter has read anything we've written. For years, we've railed against Big Pharma. Here are just a few examples...
Last year, Porter Stansberry said he wanted to get out of the traditional newsletter business.
So Porter, Steve Sjuggerud, and I designed something completely different than how we usually do things.
Last year, I helped create something unlike anything else we've ever published at Stansberry Research.
It was our way of getting as close to a "completely done for you" portfolio... with three different solutions, each tailored for a slightly different individual with different investment goals.
It's 60 degrees here at our Baltimore office... about 20 degrees warmer than usual this time of year.
Last week, the East Coast was in the grip of a winter storm. Even in Maryland, we felt sub-zero temperatures.
Ignore the crowd...
That's some of the best investment advice I can give... But it's the hardest to follow.
Regular readers know I travel all over the U.S. (and the globe). I love to move, but my travels also help me stay connected to the many businesses and economies around the country.
For example, when I stay at a Hampton Inn in Madison, Wisconsin, I mingle in the morning with folks enjoying the great breakfast foods. (I love the self-made waffles.) I might hear about a new pipe or valve company, or chat up nurses in town to learn their thoughts on electronic medical record (EMR) systems.
In 2011, our firm did something Porter still regrets.
At the time, Netflix had plunged nearly 75%... from about $42 per share down to $12.
"I think this is probably the most brilliant idea I've ever seen us produce."
That's what my good friend and publisher Porter Stansberry is saying about his new stock strategy.